The Basser Center for BRCA is pleased to partner with FORCE, Facing Our Risk of Cancer Empowered. FORCE increases awareness and provides support and education to those facing hereditary breast and ovarian cancer. FORCE helps these individuals to know their health care options and make informed decisions.
Our collaboration will strengthen ties between people coping with BRCA-related issues and the researchers and physicians devoted to finding new ways to prevent and treat BRCA-related cancers. "Individuals involved with FORCE can play a key role in helping us shape our research agenda by telling us about their experiences and helping us understand what information and resources are important to them as they navigate the process of receiving genetic test results, planning strategies to reduce their risk of developing cancer, or receiving treatment for the diseases linked to these genes," says Susan Domchek, MD, Executive Director of the Basser Center for BRCA. "Working with FORCE provides us with a terrific opportunity to connect with a motivated group of people across the nation who want to be our partners as we work toward improving the care we can offer them."
FORCE and the Basser Center work together to develop educational resources, drive research forward, and ensure that support resources are available to individuals facing hereditary breast and ovarian cancer.
Hear what FORCE and the Basser Center have to say about our partnership here!
The Basser Center for BRCA thanks the nearly 300 attendees of the 2014 Joining FORCEs Conference who joined the Basser Research Registry! 'We are continually impressed by the enthusiastic support of research shown by FORCE members. It would take us months to recruit that many carriers through our Cancer Risk Evaluation Program," says Becca Mueller, CGC.
More than 700 individuals facing hereditary breast and ovarian cancer gathered at the Philadelphia Marriott for the 2014 Joining FORCEs Conference held by Facing Our Risk of Cancer Empowered in partnership with the Basser Center for BRCA.